slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 5,461-5,490
Pages 350
Rows per page 30
Slide type
5,461-5,490 of 10,471
58
The chart shows tumour volume over time for various dosing regimens, with statistical significance indicated by ****.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
69
The chart shows dose-dependent tumour volume reduction over time compared to vehicle control.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
71
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
The slide uses a grid layout to present 8 distinct KPIs, including ARR, growth rates, retention, and cash position.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Loop · Why Now1 hit
13
The slide uses visual evidence (photos and screenshots) to establish credibility through association with major tech platforms.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
23
FiscalNote | Investor Presentation Deck | 32 slidesFiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
08
The slide uses a timeline to establish market validation through historical M&A and financing events.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution1 hit
11
The slide uses a document-style container for patient background and icon-based lists for clinical outcomes.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
12
The slide uses a process-flow layout to show the trial design and its downstream impact (publications and Phase 3).Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
Data table presents ORR, Duration of Response, CA-125 response, PFS, and OS across patient subgroups.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
Includes a spider plot (tumor shrinkage over time) and a waterfall plot (duration of response).Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
The slide uses a series of bar charts to compare PFS across multiple treatment regimens for three specific patients (15B-01, 15B-15, 15B-17).Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
Kaplan-Meier survival curve showing patient outcomes.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
19
Includes Kaplan-Meier survival curves and dose escalation scatter plots for two distinct patient groups.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
Includes two specific patient case studies with longitudinal data and RECIST response metrics.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
21
Includes a bio for Benny Li, PhD, CEO of Newsoara.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
22
The table outlines a strategic partnership involving funding and regional commercialization rights.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
32
Genelux | Investor Presentation Deck | 38 slidesGenelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
36
The slide uses a before-and-after comparison of histology images and corresponding infiltration histograms to demonstrate drug efficacy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
37
Includes a clinical case study (Pt #15A-05) with ELISPOT data and longitudinal tumor lesion size tracking.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
06
The slide uses a world map as a background watermark. Revenue is broken down by business segment.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · Traction1 hit
14
The slide uses two bar charts to demonstrate growth and productivity metrics.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
The slide uses a chronological list for service expansion and a logo grid for acquisitions.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
19
The slide uses a cascading table design to show multiple #1 rankings across different sectors.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
26
The slide highlights financial resilience and scalability through historical data.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · Traction1 hit
27
The chart displays revenue in millions, broken down by Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · Traction1 hit
10
The slide uses three distinct bar charts to demonstrate financial health across different business segments and profitability metrics.Lazard | Investor Presentation Deck | 45 slides · Lazard
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
11
The slide uses a consistent 5-quarter time series (2Q22-2Q23) across all charts.Lazard | Investor Presentation Deck | 45 slides · Lazard
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide uses a combination of bar charts for total values and line charts for secondary metrics (Average Fees and Earnings from Operations).Lazard | Investor Presentation Deck | 45 slides · Lazard
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide uses a dual-column layout: a table for current AUM and a timeline for historical team additions.Lazard | Investor Presentation Deck | 45 slides · Lazard
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit